A new study by researchers from NHG Health’s Institute of Mental Health (IMH) and NTU Singapore Lee Kong Chian School of Medicine (LKCMedicine) has identified blood-based proteomic biomarkers that may help predict who among the at-risk group is at increased risk of developing psychosis. These biomarkers refer to specific patterns of proteins circulating in blood plasma, which reflect underlying biological processes and may provide objective indicators of disease risk.